Authors
Latest:
Impact of COVID-19 on Phase I Clinical ActivitiesLife sciences companies challenged by need to minimize health risks without sacrificing data quality during pandemic.
Latest:
COVID-19 Will Have a Heterogeneous Impact on Clinical Trials, BiopharmasA discussion of how the coronavirus pandemic will have a multitude of impacts on the conduct of trials, as well as on the industry itself.
Latest:
Remembering That TIME Magazine Issue; Celebrating Progress in Patient EngagementLooking to the past reminds industry of great strides taken in clinical research for patients.
Latest:
Unlocking Oncology Insights - Innovations in Evidence Generation With RWE SolutionsThe rapid evolvement of precision oncology requires real-world data generated at a scale that unlocks insights that can not be provided from clinical trial evidence. Machine learning and large language models can be used to quickly identify information, supporting custom integrated real-world evidence solutions to make informed decisions.
Latest:
eSource Interoperability Between EHR and EDCEvidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Latest:
How to Determine ‘Good Science’ for Systematic Literature Reviews in Clinical Research and DevelopmentBest practices for assessing publications.
Latest:
Using Machine Learning to Predict Placebo Response and Increase Clinical Trial SuccessA look at the prevalence of placebo response in clinical trials and how advanced solutions can mitigate the risk it poses to drug development.
Latest:
How DCT Technology Can Enable Follow-up Clinical StudiesResearch can reveal vital information about treatments in the long run.
Latest:
Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
Latest:
eSource Interoperability Between EHR and EDCEvidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
Latest:
Clinical Study Audits: The Quality Management ApproachAdvancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.
Latest:
Accelerating Clinical Trial Design and OperationsFully-integrated, component-based CDMS offers flexibility, customization, and efficiency.
Latest:
Transforming Clinical Event Adjudication in the Era of COVID-19There's no one-size-fits-all approach during the COVID-19 pandemic
Latest:
Where Do We Go From Here?Lessons from six months of conducting clinical trials during the COVID-19 pandemic
Latest:
Rethinking ECOG Scores to Improve Patient Access and Clinical Trials EligibilityRecent study results highlight need for new metrics in ECOG scoring to mitigate variability.
Latest:
How a Global Privacy Standard Can Boost Patient TrustRegulations that apply across geographic borders can provide researchers and patients a firmer foundation on data protection.
Latest:
5 Ways DCTs Can Positively Impact Trial DiversityCOVID-19 forces life sciences industry to make long overdue changes.
Latest:
Advancing COPD Research: Harnessing Wearable Sensors and Remote Monitoring for Improved InsightsWearable sensors and remote monitoring technology can help HCPs monitor and manage COPD more effectively.
Latest:
Employing the Power of Bayesian Methods to Expedite LearningBayesian methods bring flexibility and speed to clinical trial design and analysis, and with increased access to the necessary computational power, are transforming today’s clinical research.
Latest:
Clinical Trials Supply Chain: How to Respond to Recent TransformationsConcept of flexibility acting as driving force behind industry’s swift response to COVID-19.
Latest:
Towards Data-Driven Clinical Trial Planning and StrategyOptimizing feasibility through increased data collection.
Latest:
How to Address—and Overcome—Operational Challenges in Master Protocol StudiesTrials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
Latest:
What Patients Expect from Clinical Trials in the COVID-19 EraKey takeaways from a survey of 250 oncology patients measuring COVID-19’s impact on patient willingness to participate in clinical trials.
Latest:
Immunomodulators and Cancer ResearchDistinguishing CAR-T and CPI approaches and the clinical trial challenges and complexities associated with each.
Latest:
Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
Latest:
Confidentiality in DCT: How to Utilize Third-Party Home Health ProvidersAlleviating sponsor and investigator concerns around sharing of remote-assessment data in accordance with GCP and GDPR standards.
